Chelsea Therapeutics International, Ltd. 4
4 · Chelsea Therapeutics International, Ltd. · Filed Aug 29, 2005
Insider Transaction Report
Form 4
Riehle J Nick
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2005-08-25−14,663→ 44,020 totalExercise: $0.07Exp: 2014-07-01→ Common Stock (58,683 underlying) - Exercise/Conversion
Common Stock
2005-08-25$0.07/sh+14,663$1,000→ 14,663 total
Holdings
- 68,923
Stock Option (Right to Buy)
Exercise: $2.62Exp: 2015-01-10→ Common Stock (68,923 underlying)
Footnotes (2)
- [F1]Option vests in two equal annual installments beginning on July 1, 2005.
- [F2]Option vests in two equal annual installments beginning on January 10, 2006.